Reports by Albhaisi et al. highlighted the burden of non-alcoholic fatty liver disease in lean individuals, emphasizing insulin resistance and genetic susceptibility as key contributors [34]. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.